Breaking News Bar

Business News and Information

Recent Quotes
My Watchlist
Indicators
Local Stocks
The Daily Herald Market Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biocryst Pharma Inc (NQ: BCRX )

10.92 USD -0.95 (-8.00%)
Official Closing Price Updated: 7:59 PM EST, Mar 4, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Biocryst Pharma Inc

< Previous 1 2
...
19 20 21 22 23 24 25 26 Next >
BioCryst Awarded Additional $77.2 Million by the U.S. Department of Health & Human Services To Develop Peramivir for Influenza
From PR Newswire
BioCryst Receives Peramivir Request for Proposal From the U.S. Government
From PR Newswire
BioCryst to Present at UBS Global Life Sciences Conference
From PR Newswire
Stock in Focus: Sunwin International Neutraceuticals -- September 16, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Stock Market Alerts LLC. 
From Marketwired News Releases
BioCryst Announces Partnerships for Peramivir for Influenza Outside the U.S.
From PR Newswire
BioCryst Executives to Present at Two Investor Conferences
From PR Newswire
Stock on the Move: China Armco Metals -- August 25, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Stock Market Alerts LLC. 
From Marketwired News Releases
Market Pulse Breaking News Alert for Tuesday, August 25, 2009: MNGA -- MagneGas Appoints Internal Manufacturer's Rep to Further Promote Fuel Sales in the $680 MM Metal Working Market!
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Market Pulse. 
From Marketwired News Releases
The Boston Chapter of the National Investor Relations Institute Announces its Board of Directors
From Business Wire News Releases
BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update
From PR Newswire
BioCryst Pharmaceuticals to Announce Second Quarter 2009 Financial Results on July 30, 2009
From PR Newswire
BullMarket.com Updates Outlook on Swine Flu Stocks
From PR Newswire
BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza
From PR Newswire
StreetInvesting.com Free Research on PFCB, LOGI, BCRX, PSYS, LULU and CVLT
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by StreetInvesting.com (SI). 
From Marketwired News Releases
BioCryst Pharmaceuticals Announces Presentation of Forodesine Data at the 45th Annual Meeting of the American Society of Clinical Oncology
From PR Newswire
BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results
From PR Newswire
BioCryst Pharmaceuticals to Announce Peramivir Update and First Quarter 2009 Financial Results on May 8, 2009
From PR Newswire
WallStSense.com Free Research Report for Shareholders of BCRX, AVII, ATLS and ONXX
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by WallStSense.com 
From Marketwired News Releases
Tickerspy.com Announces New Stock Index Tracking Companies Seeking Treatments and Vaccines for Swine Flu and Avian Flu
From PR Newswire
Data from Phase 2 Study of Peramivir in Patients Hospitalized with Influenza Presented at the XI International Symposium on Respiratory Viral Infections
From PR Newswire
BioCryst Reports Fourth Quarter and Year End 2008 Financial Results and Provides Corporate Update
From PR Newswire
BioCryst to Present at the 11th Annual BIO CEO & Investor Conference
From PR Newswire
BioCryst Pharmaceuticals to Announce Fourth Quarter and Year End 2008 Financial Results on February 6, 2009
From PR Newswire
BioCryst to Present at the J.P. Morgan 27th Annual Healthcare Conference
From PR Newswire
BioCryst Pharmaceuticals Elects Stanley C. Erck to its Board of Directors
From PR Newswire
BioCryst Pharmaceuticals Continues Forodesine HCl Program in Chronic Lymphocytic Leukemia
From PR Newswire
BioCryst to Present Three Posters During the 50th American Society of Hematology Annual Meeting and Exposition
From PR Newswire
BioCryst to Present at the Rodman and Renshaw 10th Annual Healthcare Conference
From PR Newswire
BioCryst Reports Third Quarter 2008 Financial Results and Provides Corporate Update
From PR Newswire
BioCryst Reports Positive Results From a Phase 2 Study of Intravenous Peramivir for Outpatient Influenza
From PR Newswire
< Previous 1 2
...
19 20 21 22 23 24 25 26 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear
Search DailyHerald.com for articles
More ways to search Daily Herald
Obituaries
Search DailyHerald.com obituaries. » Daily Herald newspaper archive
Find archived newspaper articles back to 1901. »
Digital Subscriptions
Activate Subscriber Access Purchase a Digital Subscription
Home Delivery
Start a New Subscription Manage Account